公开(公告)号：US11267813B2

公开(公告)日：2022-03-08

申请号：US16644076

申请日：2018-08-31

Applicant: BIONTECH SE

Inventor： Christophe Henry

IPC: C07D471/04 ,  A61P35/00

Abstract: The invention relates to imidazoquinoline derivatives and to pharmaceutical compositions containing the imidazoquinoline derivatives. The imidazoquinoline derivatives of the invention are useful as toll-like receptor agonists, in particular agonists of TLR7, and promote induction of certain cytokines.

公开(公告)号：US12054485B2

公开(公告)日：2024-08-06

申请号：US17590550

申请日：2022-02-01

Applicant: BIONTECH SE

Inventor： Christophe Henry

IPC: C07D471/04 ,  A61P35/00

CPC classification number: C07D471/04 ,  A61P35/00

Abstract: The invention relates to imidazoquinoline derivatives and to pharmaceutical compositions containing the imidazoquinoline derivatives. The imidazoquinoline derivatives of the invention are useful as toll-like receptor agonists, in particular agonists of TLR7, and promote induction of certain cytokines.

公开(公告)号：US11987569B2

公开(公告)日：2024-05-21

申请号：US17669117

申请日：2022-02-10

Applicant: BIONTECH SE

Inventor： Christophe Henry

IPC: A61P35/00 ,  C07D401/04 ,  C07D471/04

CPC classification number: C07D401/04 ,  A61P35/00 ,  C07D471/04

Abstract: The invention relates to imidazoquinoline derivatives and to pharmaceutical compositions containing the imidazoquinoline derivatives. The imidazoquinoline derivatives of the invention are useful as toll-like receptor agonists, in particular agonists of TLR7, and promote induction of certain cytokines.

公开(公告)号：US11279684B2

公开(公告)日：2022-03-22

申请号：US16644079

申请日：2018-08-31

Applicant: BIONTECH SE

Inventor： Christophe Henry

IPC: A61P35/00 ,  C07D471/04 ,  C07D401/04

Abstract: The invention relates to imidazoquinoline derivatives and to pharmaceutical compositions containing the imidazoquinoline derivatives. The imidazoquinoline derivatives of the invention are useful as toll-like receptor agonists, in particular agonists of TLR7, and promote induction of certain cytokines.